Compare BOLT & GXAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BOLT | GXAI |
|---|---|---|
| Founded | 2015 | 2021 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.5M | 11.7M |
| IPO Year | 2021 | 2022 |
| Metric | BOLT | GXAI |
|---|---|---|
| Price | $5.21 | $1.27 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $34.00 | N/A |
| AVG Volume (30 Days) | 14.8K | ★ 545.5K |
| Earning Date | 05-11-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 71.35 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $7,695,000.00 | $1,933,030.00 |
| Revenue This Year | N/A | $271.23 |
| Revenue Next Year | $133.33 | $36.32 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | 0.07 | ★ 47901.74 |
| 52 Week Low | $0.26 | $1.02 |
| 52 Week High | $7.35 | $2.96 |
| Indicator | BOLT | GXAI |
|---|---|---|
| Relative Strength Index (RSI) | 61.25 | 49.84 |
| Support Level | $5.24 | $1.21 |
| Resistance Level | $6.12 | $1.31 |
| Average True Range (ATR) | 0.47 | 0.07 |
| MACD | 0.08 | 0.01 |
| Stochastic Oscillator | 75.17 | 49.91 |
Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.
Gaxos.AI Inc is revolutionizing the way humans interact with artificial intelligence. The company offers applications related to mental and physical well-being, coaching, and gaming. The group is committed to tackling contemporary challenges such as how to live healthier and how to live longer. In addition to offering human-centered solutions, the company uses empathetic and AI technologies.